An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants
Trina Ekawati Tallei(Sam Ratulangi University), İsmail Çeli̇k(Erciyes University), Rownak Jahan(University of Development Alternative), Fatimawali Fatimawali(Sam Ratulangi University), Taha Alqahtani(King Khalid University), Wolfgang Sippl(Paradise Valley Community College), Mohammed Rahmatullah(University of Development Alternative), Md. Arif Khan(University of Development Alternative), Ali Alqahtani(University of Toledo), Afriza Yelnetty(Sam Ratulangi University), Talha Bin Emran(Brown University), Saeed A. Asiri(Najran University), Diah Kusumawaty(Indonesia University of Education), Shafi Mahmud(University of Rajshahi), Talha Z. Yesiloglu(Martin Luther University Halle-Wittenberg), Rinaldi Idroes(Universitas Syiah Kuala)
Cited by 50
Related Papers
Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches
|Frontiers in Oncology|2022|531
Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study
|Scientifica|2020|272
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation
|Frontiers in Cellular and Infection Microbiology|2022|241
Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases
|Molecules|2017|198